e-Drug3D 736 |
ZILEUTON
|
cas 111406-87-2 |
CLASS ANTIINFLAMMATORY |
ROUTE (list) ORAL |
ATC code |
PK parameters Tmax 1.7 HOUR Solubility PRACTICALLY INSOLUBLE IN WATER |
Target TARGET 5-LIPOXYGENASE |
DrugCentral Arachidonate 5-lipoxygenase UNIPROT P09917 ALOX5 |
Download SDF file | 1-[1-(1-benzothiophen-2-yl)ethyl]-1-hydroxyurea Formula: Calculated chemical properties: MW 236.30 NB_atoms 16 XLogP 2.73 PSA 59.385 NB_HD 3 NB_HA 4 fsp3 0.18 Lipinski(0=no;1=yes) 1 |
FDA NDA 020471 (pdf not found) INN (ZILEUTON) ZYFLO (CHIESI) APPROVAL= AP YEAR= 1996 NDA 022052 (pdf not found) INN (ZILEUTON) ZYFLO CR (CHIESI) APPROVAL= AP YEAR= 2007 DISCONTINUED NDA 204929 (pdf not found) INN (ZILEUTON) ZILEUTON (RISING) APPROVAL= AP YEAR= 2017 NDA 211972 (pdf not found) INN (ZILEUTON) ZILEUTON (LUPIN LTD) APPROVAL= AP YEAR= 2019 DISCONTINUED NDA 212670 (pdf not found) INN (ZILEUTON) ZILEUTON (STRIDES PHARMA) APPROVAL= AP YEAR= 2019 NDA 211390 (pdf not found) INN (ZILEUTON) ZILEUTON (AIZANT) APPROVAL= AP YEAR= 2020 NDA 211043 (pdf not found) INN (ZILEUTON) ZILEUTON (TEVA PHARMS USA) APPROVAL= AP YEAR= 2022 DISCONTINUED NDA 215742 (pdf not found) INN (ZILEUTON) ZILEUTON (ANNORA PHARMA) APPROVAL= AP YEAR= 2022 |
Other links: |